Who to call at Carisma Therapeutics Inc., and when
Fundz watches for the moments Carisma Therapeutics Inc. starts buying, and tells you who to reach.
- An alert the day Carisma Therapeutics Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Carisma Therapeutics Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Carisma Therapeutics Inc.. With Fundz connected, it knows.
Carisma Therapeutics Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
elevenbio.comLeadership shakeup: 3 executive changes at Eleven Biotherapeutics, Inc. in the last 90 days. Clusters like this usually mean more senior seats open over the next few months.
See every company with multiple executive changes →AI Executive Summary
AI-powered analysis of 8-K filing content
Carisma Therapeutics notified its President and CEO, Steven Kelly, and its Chief Scientific Officer, Michael Klichinsky, that their employment will end without cause as part of an orderly wind down of operations. The filing signals that the company is actively trying to sell or monetize its remaining assets and has no continuing senior management team in place.
Key Takeaways
Kelly's employment ends November 15, 2025, and Klichinsky's ends October 15, 2025, both without cause, which removes the CEO and CSO from the company.
Kelly's separation package includes 12 months of base salary, 100% of his 2025 target bonus pro-rated to November 15, and a monthly payment of $3,757 for up to 12 months, all subject to a release of c
3 more takeaways
Related Filings (2)
2 more filings from Carisma Therapeutics Inc. in the last 90 days
Filing Overview
What This Means
Carisma Therapeutics Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.